Study #2021-0669
Breast Radiation-induced Immunologic Genomic Hypofractionated Temporal Radiation Alterations DNA damage (BRIGHT-RAD) study
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study assesses changes to the immune cells following hypofractionated radiation-induced DNA damage in breast cancer patients. Radiation therapy may cause immune cells to enter tumors and target cancer cells. The goal of this study is to measure the change in the level of immune cells in the tumor before and after radiation therapy.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Breast Carcinoma, Invasive Breast Carcinoma
Study phase:
Physician name:
Simona Shaitelman
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop UT MD Anderson
Show your support for our mission through branded merchandise.